全球 CRISPR 技术市场规模、份额、趋势和成长分析报告（2026-2034 年）

CRISPR 技术市场预计将从 2025 年的 73.4 亿美元成长到 2034 年的 297.8 亿美元，2026 年至 2034 年的复合年增长率为 16.84%。

受基因编辑技术和生物技术研究进展的推动，全球CRISPR技术市场正快速成长。 CRISPR系统能够实现精准的基因修饰，支持在治疗方法、农业和生物医学研究等领域的应用。基因组学和个人化医疗领域投资的增加正在加速市场扩张。

关键成长要素包括研究经费的增加、基因治疗需求的成长以及基因编辑精度和效率的技术进步。製药公司正在积极探索基于CRISPR技术的遗传疾病和癌症治疗方法。然而，伦理问题和监管方面的复杂性仍然是重要的考量。

展望未来，基因编辑疗法的持续临床试验和商业化将塑造市场发展。农业生物技术领域应用的拓展以及合作研究倡议将进一步推动市场成长。随着法规结构的完善，CRISPR技术有望在医学和生命科学领域发挥变革性作用。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球CRISPR技术市场：依产品与服务划分

• 市场分析、洞察与预测
• 产品
• 服务

第五章 全球 CRISPR 技术市场：按应用划分

• 市场分析、洞察与预测
• 药物发现与开发
• 农业
• 其他用途

第六章 全球CRISPR技术市场：依最终使用者划分

• 市场分析、洞察与预测
• 製药和生物技术公司
• 学术研究机构
• 其他（CRO 和 CDMO）

第七章 全球CRISPR技术市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Thermo Fisher Scientific Inc
  • Merck KGaA
  • Agilent Technologies Inc
  • Genscript Biotech Corporation
  • CRISPR Therapeutics AG
  • Editas Medicine
  • Intellia Therapeutics Inc
  • Beam Therapeutics Inc
  • Caribou Biosciences Inc
  • Lonza Group Ltd
  • Danaher Corporation

The CRISPR Technology Market size is expected to reach USD 29.78 Billion in 2034 from USD 7.34 Billion (2025) growing at a CAGR of 16.84% during 2026-2034.

The global CRISPR technology market is growing rapidly due to advancements in gene editing and biotechnology research. CRISPR systems enable precise genetic modifications, supporting applications in therapeutics, agriculture, and biomedical research. Increasing investment in genomics and personalized medicine is accelerating market expansion.

Key drivers include rising research funding, growing demand for gene-based therapies, and technological improvements in editing accuracy and efficiency. Pharmaceutical companies are actively exploring CRISPR-based treatments for genetic disorders and cancer. However, ethical concerns and regulatory complexities remain important considerations.

Looking forward, continued clinical trials and commercialization of gene-editing therapies will shape market evolution. Expanding agricultural biotechnology applications and collaborative research initiatives will further support growth. As regulatory frameworks mature, CRISPR technology is expected to play a transformative role in medicine and life sciences.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product & Services

• Products
• Services

By Application

• Drug Discovery & Development
• Agriculture
• Other Applications

By End User

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Others (CROs & CDMOs)

COMPANIES PROFILED

• Thermo Fisher Scientific Inc, Merck KGaA, Agilent Technologies Inc, Genscript Biotech Corporation, CRISPR Therapeutics AG, Editas Medicine, Intellia Therapeutics Inc, Beam Therapeutics Inc, Caribou Biosciences Inc, Lonza Group Ltd, Danaher Corporation
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CRISPR TECHNOLOGY MARKET: BY PRODUCT & SERVICES 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product & Services
• 4.2. Products Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CRISPR TECHNOLOGY MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Drug Discovery & Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Agriculture Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CRISPR TECHNOLOGY MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others (CROs & CDMOs) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CRISPR TECHNOLOGY MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product & Services
  • 7.2.2 By Application
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product & Services
  • 7.3.2 By Application
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product & Services
  • 7.4.2 By Application
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product & Services
  • 7.5.2 By Application
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product & Services
  • 7.6.2 By Application
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL CRISPR TECHNOLOGY INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Thermo Fisher Scientific Inc
  • 9.2.2 Merck KGaA
  • 9.2.3 Agilent Technologies Inc
  • 9.2.4 Genscript Biotech Corporation
  • 9.2.5 CRISPR Therapeutics AG
  • 9.2.6 Editas Medicine
  • 9.2.7 Intellia Therapeutics Inc
  • 9.2.8 Beam Therapeutics Inc
  • 9.2.9 Caribou Biosciences Inc
  • 9.2.10 Lonza Group Ltd
  • 9.2.11 Danaher Corporation